BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 33864000)

  • 21. Oncometabolites in cancer aggressiveness and tumour repopulation.
    Dando I; Pozza ED; Ambrosini G; Torrens-Mas M; Butera G; Mullappilly N; Pacchiana R; Palmieri M; Donadelli M
    Biol Rev Camb Philos Soc; 2019 Aug; 94(4):1530-1546. PubMed ID: 30972955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
    Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
    Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer. Puzzling patterns of predisposition.
    Pollard PJ; Ratcliffe PJ
    Science; 2009 Apr; 324(5924):192-4. PubMed ID: 19359573
    [No Abstract]   [Full Text] [Related]  

  • 24. Activities of enzymes of the citric acid cycle and electron transport chain in the skeletal muscle of normal and dystrophic mice (strain 129).
    Jato-Rodriguez JJ; Hudson AJ; Strickland KP
    Enzyme; 1972; 13(5-6):286-92. PubMed ID: 4376082
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer.
    Sciacovelli M; Frezza C
    FEBS J; 2017 Oct; 284(19):3132-3144. PubMed ID: 28444969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial metabolic remodeling in response to genetic and environmental perturbations.
    Hollinshead KE; Tennant DA
    Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):272-85. PubMed ID: 27196610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma.
    Richter S; Gieldon L; Pang Y; Peitzsch M; Huynh T; Leton R; Viana B; Ercolino T; Mangelis A; Rapizzi E; Menschikowski M; Aust D; Kroiss M; Beuschlein F; Gudziol V; Timmers HJ; Lenders J; Mannelli M; Cascon A; Pacak K; Robledo M; Eisenhofer G; Klink B
    Genet Med; 2019 Mar; 21(3):705-717. PubMed ID: 30050099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
    Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
    Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The tricarboxylic acid cycle in L₃ Teladorsagia circumcincta: metabolism of acetyl CoA to succinyl CoA.
    Simcock DC; Walker LR; Pedley KC; Simpson HV; Brown S
    Exp Parasitol; 2011 May; 128(1):68-75. PubMed ID: 21320492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity.
    Azzimato V; Chen P; Barreby E; Morgantini C; Levi L; Vankova A; Jager J; Sulen A; Diotallevi M; Shen JX; Miller A; Ellis E; Rydén M; Näslund E; Thorell A; Lauschke VM; Channon KM; Crabtree MJ; Haschemi A; Craige SM; Mori M; Spallotta F; Aouadi M
    Gastroenterology; 2021 Dec; 161(6):1982-1997.e11. PubMed ID: 34425095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
    Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
    Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetically-defined metabolic reprogramming in cancer.
    Mullen AR; DeBerardinis RJ
    Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tricarboxylic acid cycle enzymes of the ectomycorrhizal basidiomycete, Suillus bovinus.
    Grotjohann N; Huang Y; Kowallik W
    Z Naturforsch C J Biosci; 2001; 56(5-6):334-42. PubMed ID: 11421446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Central metabolism in Acinetobacter sp. grown on ethanol].
    Pirog TP; Kuz'minskaia IuV
    Mikrobiologiia; 2003; 72(4):459-65. PubMed ID: 14526533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.
    Koivunen P; Hirsilä M; Remes AM; Hassinen IE; Kivirikko KI; Myllyharju J
    J Biol Chem; 2007 Feb; 282(7):4524-4532. PubMed ID: 17182618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of simultaneous quantitative analysis of tricarboxylic acid cycle metabolites to identify specific metabolites in cancer cells by targeted metabolomic approach.
    Yamamoto T; Sato K; Yamaguchi M; Mitamura K; Taga A
    Biochem Biophys Res Commun; 2021 Dec; 584():53-59. PubMed ID: 34768082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients.
    Bubber P; Hartounian V; Gibson GE; Blass JP
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):254-60. PubMed ID: 21123035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variants in genes of tricarboxylic acid cycle key enzymes predict postsurgical overall survival of patients with hepatocellular carcinoma.
    Du X; Wan S; Chen Y; Qu P; Huang X; Yu X; Yang H; Zhang Y; Xing J
    Ann Surg Oncol; 2014 Dec; 21(13):4300-7. PubMed ID: 25081338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State.
    Cardaci S; Ciriolo MR
    Int J Cell Biol; 2012; 2012():161837. PubMed ID: 22888353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic enzymes as oncogenes or tumor suppressors.
    Thompson CB
    N Engl J Med; 2009 Feb; 360(8):813-5. PubMed ID: 19228626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.